ADVFN ADVFN

Hot Features

Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Qiagen NV

Qiagen NV (QGEN)

36,68
-0,88
(-2,34%)
Fermé 07 Juin 10:00PM
36,68
0,00
(0,00%)
Après les heures de négociation: 1:59AM

Qiagen NV (QGEN) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
36,68
( -2,34% )
Prix Achat
-
Prix Vente
-
Volume échangé
1 412 913
36,54 Fourchette du Jour 37,81
32,53 Plage de 52 semaines 57,815
Cap du marché
Clôture Veille
37,56
Ouverture
37,67
Dernière Transaction
140715
@
36.68
Dernière heure de transaction
Volume financier
US$ 51 973 749
VWAP
36,7848
Volume moyen (3 m)
US$ 2 083 501
Actions en circulation
206 800 618
Rendement du Dividende (LTM)
0 (7,24%)
Ratio Cours sur Bénéfices
18,4
Bénéfice par action (BPA)
1,94
Chiffre d'affairess (LTM)
2,1B
Bénéfice net (LTM)
402,17M

À propos de Qiagen NV

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene ... Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Venlo, Netherlands
Fondé
1984
Qiagen NV est coté dans le secteur Healthcare de la New York Stock Exchange avec le ticker QGEN. Le dernier cours de clôture d'Qiagen NV était de US$37,56. Au cours de la dernière année, les actions de Qiagen NV ont été négociées dans une fourchette de prix de US$ 32,53 à US$ 57,815.

Qiagen NV compte actuellement 206 800 618 actions en circulation. La capitalisation boursière d'Qiagen NV est de US$7,59 milliard. Qiagen NV a un ratio cours/bénéfice (ratio PE) de 18.40.

QGEN Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.060.16384489350136.6238.135.46271235236.5401416CS
43.249.6889952153133.4438.132.53237044334.81876518CS
12-5.15-12.311737987141.8342.3332.53205162136.87078CS
26-10.79-22.73014535547.4757.81532.53216564444.03584045CS
52-9.32-20.26086956524657.81532.53173404845.23604692CS
156-9.43-20.451095207146.1157.81532.53137437643.87213776CS
260-9.96-21.355060034346.645832.53115866345.10486754CS

QGEN - Frequently Asked Questions (FAQ)

What is the current Qiagen NV share price?
The current share price of Qiagen NV is US$ 36,68
How many Qiagen NV shares are in issue?
Qiagen NV has 206 800 618 shares in issue
What is the market cap of Qiagen NV?
The market capitalisation of Qiagen NV is USD 7,59B
What is the 1 year trading range for Qiagen NV share price?
Qiagen NV has traded in the range of US$ 32,53 to US$ 57,815 during the past year
What is the PE ratio of Qiagen NV?
The price to earnings ratio of Qiagen NV is 18,4
What is the cash to sales ratio of Qiagen NV?
The cash to sales ratio of Qiagen NV is 3,52
What is the registered address of Qiagen NV?
The registered address for Qiagen NV is Hulsterweg 82, Venlo, Limburg, 5912 PL
What is the Qiagen NV website address?
The website address for Qiagen NV is www.qiagen.com
Which industry sector does Qiagen NV operate in?
Qiagen NV operates in the Biotechnology & Life Sciences sector

QGEN Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion